These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 3080099

  • 21. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
    Caniggia A, Gennari C, Guideri R, Vattimo A, Nardi P.
    Minerva Med; 1976 Jan 07; 67(1):1-15. PubMed ID: 814505
    [Abstract] [Full Text] [Related]

  • 22. Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry.
    Meunier PJ, Chapuy MC, Delmas P, Charhon S, Edouard C, Arlot M.
    Am J Med; 1987 Feb 23; 82(2A):71-8. PubMed ID: 3103438
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
    Khairi MR, Altman RD, DeRosa GP, Zimmermann J, Schenk RK, Johnston CC.
    Ann Intern Med; 1977 Dec 23; 87(6):656-63. PubMed ID: 412450
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Aminohexane diphosphonate in the treatment of Paget's disease of bone.
    Atkins RM, Yates AJ, Gray RE, Urwin GH, Hamdy NA, Beneton MN, Rosini S, Kanis JA.
    J Bone Miner Res; 1987 Aug 23; 2(4):273-9. PubMed ID: 3455614
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate].
    Ravault A, Meunier PJ.
    Rev Rhum Mal Osteoartic; 1989 Mar 15; 56(4):293-302. PubMed ID: 2496461
    [Abstract] [Full Text] [Related]

  • 29. Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.
    Smith ML, Fogelman I, Ralston S, Boyce BF, Boyle IT.
    Metab Bone Dis Relat Res; 1984 Mar 15; 5(4):167-70. PubMed ID: 6429474
    [Abstract] [Full Text] [Related]

  • 30. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
    Roux C, Gennari C, Farrerons J, Devogelaer JP, Mulder H, Kruse HP, Picot C, Titeux L, Reginster JY, Dougados M.
    Arthritis Rheum; 1995 Jun 15; 38(6):851-8. PubMed ID: 7779130
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
    Harinck HI, Bijvoet OL, Blanksma HJ, Dahlinghaus-Nienhuys PJ.
    Clin Orthop Relat Res; 1987 Apr 15; (217):79-98. PubMed ID: 2951049
    [Abstract] [Full Text] [Related]

  • 35. Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.
    Boyce BF, Smith L, Fogelman I, Johnston E, Ralston S, Boyle IT.
    Lancet; 1984 Apr 14; 1(8381):821-4. PubMed ID: 6143140
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Alternate calcitonin and etidronate disodium therapy for Paget's bone disease.
    Perry HM, Droke DM, Avioli LV.
    Arch Intern Med; 1984 May 14; 144(5):929-33. PubMed ID: 6424594
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.